Andrew J. Wang

Array ( [id] => 4023237 [patent_doc_number] => 05882927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-16 [patent_title] => 'Oligonucleotide inhibition of protein kinase C' [patent_app_type] => 1 [patent_app_number] => 8/478178 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 17 [patent_no_of_words] => 18785 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/882/05882927.pdf [firstpage_image] =>[orig_patent_app_number] => 478178 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4135780 [patent_doc_number] => 06015688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Transferrin receptor genes' [patent_app_type] => 1 [patent_app_number] => 8/483577 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 144 [patent_figures_cnt] => 58 [patent_no_of_words] => 81624 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015688.pdf [firstpage_image] =>[orig_patent_app_number] => 483577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3786999 [patent_doc_number] => 05840679 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method of inhibiting P-selectin ligand activity' [patent_app_type] => 1 [patent_app_number] => 8/472576 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 40 [patent_no_of_words] => 26502 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840679.pdf [firstpage_image] =>[orig_patent_app_number] => 472576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3722357 [patent_doc_number] => 05672499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Immoralized neural crest stem cells and methods of making' [patent_app_type] => 1 [patent_app_number] => 8/478920 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 62 [patent_no_of_words] => 18607 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672499.pdf [firstpage_image] =>[orig_patent_app_number] => 478920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3999420 [patent_doc_number] => 05922841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-13 [patent_title] => 'Recombinantly produced transferrin receptor of haemophilus' [patent_app_type] => 1 [patent_app_number] => 8/478373 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 141 [patent_figures_cnt] => 145 [patent_no_of_words] => 70466 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/922/05922841.pdf [firstpage_image] =>[orig_patent_app_number] => 478373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171695 [patent_doc_number] => 06083744 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'DNA-armed ribozymes and minizymes' [patent_app_type] => 1 [patent_app_number] => 8/477934 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 16374 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083744.pdf [firstpage_image] =>[orig_patent_app_number] => 477934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759694 [patent_doc_number] => 05741683 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'In vitro packaging of adeno-associated virus DNA' [patent_app_type] => 1 [patent_app_number] => 8/477538 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9601 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741683.pdf [firstpage_image] =>[orig_patent_app_number] => 477538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619654 [patent_doc_number] => 05688689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Cloning and expression vectors in an actinomycetes strain, process for transformation of this strain, actinomycetes strain obtained and preparation of proteins' [patent_app_type] => 1 [patent_app_number] => 8/477502 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 4100 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688689.pdf [firstpage_image] =>[orig_patent_app_number] => 477502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3789984 [patent_doc_number] => 05840868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Pesticidal proteins and strains' [patent_app_type] => 1 [patent_app_number] => 8/471044 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 28073 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840868.pdf [firstpage_image] =>[orig_patent_app_number] => 471044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682732 [patent_doc_number] => 05695753 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Transglutaminases as immunosuppressants' [patent_app_type] => 1 [patent_app_number] => 8/468058 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2210 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/695/05695753.pdf [firstpage_image] =>[orig_patent_app_number] => 468058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725912 [patent_doc_number] => 05702907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Antibodies to the hepatocellular carcinoma oncogene and immunoassays using the same' [patent_app_type] => 1 [patent_app_number] => 8/471540 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 7034 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702907.pdf [firstpage_image] =>[orig_patent_app_number] => 471540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3867726 [patent_doc_number] => 05763171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Nucleic acid structures with catalytic and autocatalytic replicating features and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/468049 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22853 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763171.pdf [firstpage_image] =>[orig_patent_app_number] => 468049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006387 [patent_doc_number] => 05859221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => '2\'-modified oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/468037 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 33291 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859221.pdf [firstpage_image] =>[orig_patent_app_number] => 468037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3768313 [patent_doc_number] => 05756283 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Method for improved production of recombinant adeno-associated viruses for gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/462014 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 44 [patent_no_of_words] => 14111 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756283.pdf [firstpage_image] =>[orig_patent_app_number] => 462014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4173735 [patent_doc_number] => 06140491 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Nucleozymes' [patent_app_type] => 1 [patent_app_number] => 8/458237 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 7273 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140491.pdf [firstpage_image] =>[orig_patent_app_number] => 458237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580710 [patent_doc_number] => 06423489 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Compositions and methods for treatment of Hepatitis C virus-associated diseases' [patent_app_type] => B1 [patent_app_number] => 08/452841 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18896 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423489.pdf [firstpage_image] =>[orig_patent_app_number] => 08452841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4123105 [patent_doc_number] => 06127114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/442807 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 30 [patent_no_of_words] => 11647 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127114.pdf [firstpage_image] =>[orig_patent_app_number] => 442807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936422 [patent_doc_number] => 05929226 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Antisense oligonucleotide alkylphosphonothioates and arylphospohonothioates' [patent_app_type] => 1 [patent_app_number] => 8/436927 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7187 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929226.pdf [firstpage_image] =>[orig_patent_app_number] => 436927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738080 [patent_doc_number] => 05698687 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Modified ribozymls' [patent_app_type] => 1 [patent_app_number] => 8/434501 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8379 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698687.pdf [firstpage_image] =>[orig_patent_app_number] => 434501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831130 [patent_doc_number] => 05712128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-27 [patent_title] => 'Enzymatic RNA molecules' [patent_app_type] => 1 [patent_app_number] => 8/434453 [patent_app_country] => US [patent_app_date] => 1995-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 9586 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/712/05712128.pdf [firstpage_image] =>[orig_patent_app_number] => 434453 [rel_patent_id] =>[rel_patent_doc_number] =>)